-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Eterna Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Eterna Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $3K, a 25% decline year-over-year.
- Eterna Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$5K, a 109% decline year-over-year.
- Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was -$3K, a 107% decline from 2022.
- Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $45K, a 29.7% decline from 2021.
- Eterna Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $64K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)